CMS Open Payments · Program Year 2024
Cytyc Surgical Products, LLC
Cytyc Surgical Products, LLC reported $12,367.15 across General Payments, Research, and Ownership to 70 physicians and teaching hospitals across 70 transactions.
- $12.4K Below-median payer
- All-tracks total
- 70 Below-median volume
- Transactions
- 70 Below-median reach
- Recipients
- −$25.2K
- General Payments vs PY2023
Cytyc Surgical Products, LLC reported $12,367.15 across all CMS Open Payments tracks (General + Research + Ownership) to 70 physicians and teaching hospitals in Program Year 2024 - ranking #1610 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $12,367.15, averaging $176.67 per recipient.
How Cytyc Surgical Products, LLC's $12.4K all-tracks total breaks down
Cytyc Surgical Products, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer cytyc-surgical-products-llc Cytyc Surgical Products, LLC
$12.4K · #1610/1,925 · 0.0% industry · PY2024
- TOT $12.4K
- RANK #1610
- SHARE 0.0%
- TXN 70
- RCP 70
- CAT 3
- GEN $12.4K
- ΔGEN −$25.2K
- TOP1 14.7%
- PY 2024
Volume peers
Nearest volume peer: Sentec, Inc. ($12.3K)
Cytyc Surgical Products, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Cytyc Surgical Products, LLC's CMS-reported General Payments decreased by $25.2K (−67.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CYTYC SURGICAL PRODUCTS, LLCPY2023: CYTYC SURGICAL PRODUCTS, LLCPY2024: Cytyc Surgical Products, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $37,588.47
- PY2024
- $12,367.15
What the Data Shows for Cytyc Surgical Products, LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Cytyc Surgical Products, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 3 general-payment categories charted below, "Food and Beverage" is the largest at $5.7K across 49 transactions, 46.1% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 3 types of general payments, Cytyc Surgical Products, LLC's largest category was "Food and Beverage" at $5.7K - 46.1% of General Payments.
How Cytyc Surgical Products, LLC divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $5.7K | 49 | 46.1% |
| Travel and Lodging | $5.2K | 18 | 42.3% |
| Consulting Fee | $1.4K | 3 | 11.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $7,181.84 (58.1%) of $12,367.15 in this company's General Payments records across 18 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Cytyc Surgical Products, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Erica Robinson
$1,813.55 across 6 reported transactions
- 2
Austen Slade
$1,624.92 across 9 reported transactions
- 3
Jamal Mourad
$1,332.03 across 6 reported transactions
- 4
Michael Scheiber
$1,266.81 across 7 reported transactions
- 5
Michelle Louie
$1,144.53 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Cytyc Surgical Products, LLC ranks #1610 of 1,925 by total payments (bottom 16% by spend) but is notably more concentrated than that alone would suggest -- #1,046 of 1,838 by HHI (bottom 43% least concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Mf Med : $630.54 total payments, HHI 979
- B. Braun Medical Inc. : $221.2K total payments, HHI 975
- Vioptix Inc : $4.7K total payments, HHI 971
- Bolton Medical Inc : $2.2M total payments, HHI 970
- Ge Healthcare : $6.4M total payments, HHI 966
- Occlutech US LLC : $1.2M total payments, HHI 961
- Cytyc Surgical Products, LLC (this company) : $12.4K total payments, HHI 961
- BioXcel Therapeutics, Inc. : $116.0K total payments, HHI 958
- Spinefrontier, Inc. : $26.7K total payments, HHI 958
- PARI Respiratory Equipment, Inc. : $262.70 total payments, HHI 954
- Rayner Intraocular Lenses Limited : $262.7K total payments, HHI 950
- STRATA Skin Sciences, Inc. : $89.3K total payments, HHI 940
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Cytyc Surgical Products, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Cytyc Surgical Products, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Cytyc Surgical Products, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Validus Pharmaceuticals LLC
Biodermis LLC
Smaio USA Corporation
IMPLANET America, Inc.
Dutch Ophthalmic Research Center (International) B.V.
Put this to use
Cytyc Surgical Products, LLC ranks #1610 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Cytyc Surgical Products, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.